Clinical Trial

Brain Stimulation and Attention Control in Children With ADHD

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if brain stimulation can help children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) improve their attention and self-control. The main questions it aims to answer are: Does intermittent theta burst stimulation (iTBS) improve performance on a task that tests attention and reaction times? Can brain activity and genetics help predict who benefits most from this treatment? Researchers will compare randomly assigned active iTBS to sham (inactive) stimulation groups to see if the treatment helps. Participants will: Receive 10 sessions of either active or sham iTBS over 2 weeks Complete a computer task measuring attention before and after stimulation Wear a brain cap during the task to record EEG signals, also take part in resting-state brain scans, namely magnetic resonance imaging (MRI) and functional near-infrared spectroscopy (fNIRS), and provide a saliva sample for genetic testing
Trial Details
NCT Number NCT07182344
Lead Sponsor Neurolab Plus
Collaborators: Al-Farabi Kazakh National University
Conditions ADHD - Attention Deficit Disorder With Hyperactivity
Enrollment 40 participants
Start Date 2025-09-04
Primary Completion 2026-03 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-19